New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.
The U.S. Food and Drug Administration announced the approval of Lamisil Oral Granules for the treatment of tinea capitis, a fungal infection of the scalp, in children ages 4 years and older.
Three specialists in gastrointestinal and brain cancers recently joined the James P. Wilmot Cancer Center at the University of Rochester Medical Center to meet the growing need in the Rochester and Upstate New York region.
Ontario Liberals will take another step forward in its battle against cancer by covering prostate specific antigen (PSA) tests for men over the age of 50, said Health Minister George Smitherman from the Columbus Centre Fitness Club.
The U.S. Food and Drug Administration announced its intention to take enforcement action against companies marketing unapproved prescription drug products containing hydrocodone, a narcotic widely used to treat pain and suppress coughs. The action does not affect other hydrocodone formulations, which have FDA approval.
Participants at a United Nations-sponsored conference in Brussels have called for increased investment in vaccination, screening and treatment to eliminate cervical cancer, a preventable disease that kills 250,000 women annually – 80 per cent of them in developing countries.
The Substance Abuse and Mental Health Services Administration (SAMHSA) has awarded a four-year $1.6 million grant to the newly established University of Kentucky Center for the Study of Violence Against Children (CSVAC).
Temporarily diverting blood leaving the liver during chemotherapy could prolong the lives of people with primary or secondary liver tumours. The hour-long procedure allows massive doses of chemotherapy drugs to reach the liver and kill the cancer cells without poisoning the rest of the body.
A UCSF research team has developed a simple tool that can improve the effectiveness of communication between doctors and patients about prescribed medications and result in dramatic improvements in health and safety.
Researchers in Brazil have found that treating patients who suffer from obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) dramatically reduces early indications of atherosclerosis in just months, linking OSA directly to the hardening or narrowing of the arteries.